Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
May 2003
Features
Editor’s Memo
Editorial Board Spotlight: Mark J. Baumel, MD, MS
P&T welcomes Dr. Baumel, the newest addition to our editorial board.
Sonja Sherritze
Drug Safety Revisions: FDA Update
The author reviews new warnings and label changes for sirolimus (Rapamune®), pergolide mesylate (Permax®), and salmeterol xinafoate inhalation aerosol (Serevent®).
Marvin M. Goldenberg, PhD, RPh, MS
Physician Perspective
An Invaluable $4 Gift
A practicing physician relates the story of the best $4 he ever spent.
Thomas Marzili, MD
Cover Story
Evaluation of Beta Interferons for Multiple Sclerosis
The authors present an in-depth review of Rebif® for prevention of relapses in patients with MS.
Abby Guest, PharmD Candidate, and Richard Cramer, PharmD
Costs of Respiratory Syncytial Virus Infection at a Tertiary-Care Children’s Hospital
Determining the expenditures related to RSV infection requires diagnostic confirmation, a chart review, and an analysis of billing costs.
Ben Z. Katz, MD, Joseph Lo, MPH, and Mark Sorrentino, MD, MS
Highlights of the 52nd Scientific Session of The American College of Cardiology
Dr. Prescott reviews drug-coated stents, beta blockade, a thrombin inhibitor, a new statin, a lipid-lowering formulation, and other advances presented at the ACC meeting.
Lawrence M. Prescott, PhD
Reader Response
Response to "What’s Going to Happen to Brave Surgeons and Patients?”
Daniel McDevitt, MD, FACS
Departments
Editorial
Glossary of P&T Slang
Editor-in-Chief David Nash, MD, MBA, puts a new “spin” on some commonly used jargon in P&T committees.
David B. Nash, MD, MBA
Medication Errors
Medication Error-Prevention “Toolbox”
Matthew Grissinger discusses a set of “tools” for preventing medication errors.
Matthew Grissinger, RPh
Prescription Washington
“It’s the Hospitals, Stupid!”: Bar Code Proposal Relies on Hospitals to Buy Expensive Scanners
Stephen Barlas describes the new bar-code proposal for hospitals.
Stephen Barlas
Drug Forecast
Peginterferon alfa-2a: A New Agent for Hepatitis C Virus Infection
The authors review peg-interferon alfa-2a (Pegasys®) for the treatment of hepatitis C virus infection.
Tarrah Williams, PharmD Candidate, Marlon Honeywell, PharmD, Evans Branch III, PharmD, and Michael Thompson, BCNSP, PharmD
Drug News
New Drugs/Drug News
P&T presents the latest information about approvals, indication changes, industry updates, and news from the FDA
